Clinical Trials Logo

Clinical Trial Summary

Photobiomodulation (PBM), is FDA-approved for temporary relief of muscle and joint pain, but there is no indication for TMD. Our goal in this study is to conduct a clinical trial of multimodal PBM for TMD pain. This study will be a double-blind, sham-controlled, randomized trial testing the efficacy of PBM for pain related to TMD.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Pain Related to TMD
  • Temporomandibular Joint Disorders
  • Temporomandibular Joint Dysfunction Syndrome

NCT number NCT05916235
Study type Interventional
Source University of Florida
Contact Selenia Rubio, MD
Phone 352-273-5590
Email srubio7@ufl.edu
Status Recruiting
Phase N/A
Start date February 8, 2024
Completion date October 2028

See also
  Status Clinical Trial Phase
Terminated NCT04415281 - Photobiomodulation for the Management of Temporomandibular Disorder Pain N/A